While functional neuroplasticity cannot be directly tested in the living human brain, post-mortem studies of depression show reductions in markers of neuroplasticity, including reduced BDNF and decreased synapses and synapse-related gene expression [13, 14]. Here, BDNF is linked to depressive symptom measurement.